|Last Price||Today's Change||52-Week Range||Trading Volume|
|7.20||0.25 (+3.60%)||6.36 - 10.32||639.6 thousand (Below Avg)|
Market data as of 3:59PM 07/30/14. Quotes are delayed by at least 15 min.
Spectrum Pharmaceuticals Completes Enrollment in Phase 2 Trial of SPI-2012 - A Novel Long-Acting Granulocyte Colony Stimulating Factor (GCSF) to Treat Chemotherapy-induced Neutropenia
05/28/2014 7:00 AM ET